findmyKOL
Clinical trialNCT01720264CompletedPhase 2Interventional

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

SponsorSherif S. FaragEnrollment15Acute Lymphoid LeukemiaAcute Myeloid LeukemiaHematopoetic MyelodysplasiaLeukemia, Myelogenous, ChronicLymphoma, Non-Hodgkin
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this trial is to assess the efficacy and safety of sitagliptin in enhancing engraftment following umbilical cord blood transplantation (recovery of blood counts after transplant).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Indiana University Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana, United States

  • New York Medical College/westchester Medical Center/maria Fareri Children'S Hosptial

    Valhalla, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Sitagliptin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Nov 2012
Primary completion
27 Aug 2016
Completion
15 Dec 2017
Last update posted
8 Jan 2019
Registered enrollment
15
Registry id
NCT01720264
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.